New 25-Valent vaccine aims to broaden protection against pneumococcal disease
⭐️ VACCINE ⭐️
Completed
This study tested a new vaccine designed to protect against 25 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. About 220 healthy adults aged 18 to 49 received either the new vaccine or an existing one to compare safety and immune response. …
Phase: PHASE2 • Sponsor: Inventprise Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:00 UTC